Pfizer completes merger with Wyeth

02 Dec 2014 Evaluate

Drug major Pfizer announced completion of the merger with pharmaceutical company, Wyeth. The merger places Pfizer among the top ten drug companies in India by market share. As a result of the merger with Wyeth, Pfizer now has a significantly stronger portfolio of offerings across a wider therapeutic universe.

Pfizer Inc, USA, through its subsidiaries holds the majority stake in both companies and will continue to remain the majority shareholder with around 63.9 per cent holding in Pfizer post-merger. 

The company has debuted offering in vaccines segment and has planned to build a robust presence in areas of women's health with best known brands in Oral contraception and folic acid supplements. Pfizer reported a standalone loss of Rs 11.83 crore for the second quarter of current fiscal as compared to net profit of Rs 69.45 crore for same quarter of previous fiscal.

Pfizer Share Price

4995.25 -7.55 (-0.15%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×